Pharmaceuticals, An Open Access Pharmaceutical Sciences Journal from MDPI, new pharmaceuticals.#New #pharmaceuticals

Posted On Mar 19 2018 by

Pharmaceuticals — Open Access Pharmaceutical Sciences Journal Open Access – free for readers, with article processing charges (APC) paid by authors or their institutions. High visibility: citations available in PubMed, full-text archived in PubMed Central. Covered by Embase and Scopus. To be indexed in the Emerging Sources Citation Index – ESCI (Web of Science) from Vol. 10 (2017). CiteScore: 4.90, based on citations in 2016 to articles published 2013-2015, Rapid publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 27 days after submission; acceptance to publication is undertaken in 5 days (median values for papers published in …


Alexion Pharmaceuticals Adds New CFO From Biogen, new pharmaceuticals.#New #pharmaceuticals

Posted On Mar 19 2018 by

YahooFinance Alexion Pharmaceuticals Adds New CFO From Biogen Shares of Alexion Pharmaceuticals Inc. (ALXN) saw a handy gain early on Wednesday after the company announced that there would be changes in its leadership. The company announced that Paul J. Clancy will be assuming the chief financial officer role effective July 31, 2017. Clancy was previously the CFO of Biogen Inc. (BIIB) for the past 10 years. Prior to Biogen, Clancy spent 13 years with PepsiCo in various executive positions. Clancy will succeed Dave Anderson, who will continue to serve as CFO until July 31, 2017. To ensure a smooth transition, …


Home Page, PhRMA, new pharmaceutical companies 2013.#New #pharmaceutical #companies #2013

Posted On Mar 18 2018 by

new pharmaceutical companies 2013 PhRMA represents the country’s leading biopharmaceutical research companies and supports the search for new treatments and cures. Advocacy From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results. Science Today, cutting-edge medical science is transforming patients’ lives. Discover how scientists and researchers are advancing science. Patients Patient support and assistance is the top priority for PhRMA’s member companies, who are working hard to improve patients’ lives through the discovery and development of new medicines and treatments. Resources Explore the …


Co-Pay Coupons for Patients, but Higher Bills for Insurers – The New York Times, pharmaceutical companies in new york.#Pharmaceutical #companies #in #new #york

Posted On Mar 16 2018 by

Coupons for Patients, but Higher Bills for Insurers EXECUTIVES of a small insurance company in Albany were mystified when, almost overnight, its payments for a certain class of antibiotics nearly doubled, threatening to add about a half-million dollars annually in costs. The reason, it turned out, was that patients were using a card distributed by the maker of an expensive antibiotic used to treat acne, sharply reducing their insurance co-payments. With their out-of-pocket costs much lower, consumers had switched from generic alternatives to the more expensive drug. With drug prices rising and many people out of work, pharmaceutical companies are …


Pharmaceutical Companies of Johnson & Johnson, Janssen, new pharmaceutical companies.#New #pharmaceutical #companies

Posted On Mar 16 2018 by

new pharmaceutical companies We engage in approximately 400 active collaborations — from discovery to late-stage development — with academia, pharmaceutical and biotech peers, and other public- and private-sector partners. Partner With Us Together, we can solve problems and find transformational solutions. We believe that partnerships are essential to drive change, innovation and transformation, and we are committed to ensuring the success of our collaborations. Betsy Gross Artwork from The Creative Center at University Settlement, a nonprofit organization dedicated to bringing creative arts to people living with and beyond cancer and other chronic illnesses. Cliff Enright Artwork from The Creative Center …


About, PhRMA, new pharmaceutical companies.#New #pharmaceutical #companies

Posted On Mar 16 2018 by

About PhRMA, the Pharmaceutical Research and Manufacturers of America, represents the country’s leading innovative biopharmaceutical research companies. Our members are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. New medicines are an integral part of the health care system, providing doctors and patients with safe and effective treatment options, and improving quality of life. Key Facts About Innovative Medicines PhRMA History PhRMA was formed in 1958 to represent America’s biopharmaceutical research companies and help promote smart public policy that supports medical research to address patient needs. Headquartered in Washington, D.C., with …


Pharmaceuticals, An Open Access Pharmaceutical Sciences Journal from MDPI, new pharmaceuticals.#New #pharmaceuticals

Posted On Jan 31 2018 by

Pharmaceuticals — Open Access Pharmaceutical Sciences Journal Open Access – free for readers, with article processing charges (APC) paid by authors or their institutions. High visibility: citations available in PubMed, full-text archived in PubMed Central. Covered by Embase and Scopus. To be indexed in the Emerging Sources Citation Index – ESCI (Web of Science) from Vol. 10 (2017). CiteScore: 4.90, based on citations in 2016 to articles published 2013-2015, Rapid publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 27 days after submission; acceptance to publication is undertaken in 5 days (median values for papers published in …


Medzilla; Biotech Jobs, Pharmaceutical Jobs, Pharmaceutical Sales Jobs, Resumes, Medical Career, Job Board, Biopharmaceutical Jobs, Medical Job Search, Science Jobs, Healthcare Jobs and Biotechnology Career, pharmaceutical companies in new york.#Pharmaceutical #companies #in #new #york

Posted On Jan 30 2018 by

MedZilla This Week’s Featured Jobs Opportunity posted by Sunrise Systems Inc Opportunity posted by Sunrise Systems Inc Opportunity posted by Takeda Pharmaceuticals Opportunity posted by PDI, Inc Opportunity posted by Novartis Opportunity posted by Touchpoint Solutions Opportunity posted by Lundbeck Opportunity posted by inVentiv Health Opportunity posted by Novo Nordisk Opportunity posted by PDI, Inc View our Newest Jobs by State View our Newest Jobs by Profession Employers & Recruiters Search now, thank us later: Search our pre-screened candidates for the talents you need now for FREE! – Mark S, Sales Executive – James D, Lab Technichian – T. Baker, …


Pharmaceutical Companies of Johnson & Johnson, Janssen, new pharmaceutical companies.#New #pharmaceutical #companies

Posted On Jan 30 2018 by

new pharmaceutical companies We engage in approximately 400 active collaborations — from discovery to late-stage development — with academia, pharmaceutical and biotech peers, and other public- and private-sector partners. Partner With Us Together, we can solve problems and find transformational solutions. We believe that partnerships are essential to drive change, innovation and transformation, and we are committed to ensuring the success of our collaborations. Betsy Gross Artwork from The Creative Center at University Settlement, a nonprofit organization dedicated to bringing creative arts to people living with and beyond cancer and other chronic illnesses. Cliff Enright Artwork from The Creative Center …


Co-Pay Coupons for Patients, but Higher Bills for Insurers – The New York Times, pharmaceutical companies in new york.#Pharmaceutical #companies #in #new #york

Posted On Jan 30 2018 by

Coupons for Patients, but Higher Bills for Insurers EXECUTIVES of a small insurance company in Albany were mystified when, almost overnight, its payments for a certain class of antibiotics nearly doubled, threatening to add about a half-million dollars annually in costs. The reason, it turned out, was that patients were using a card distributed by the maker of an expensive antibiotic used to treat acne, sharply reducing their insurance co-payments. With their out-of-pocket costs much lower, consumers had switched from generic alternatives to the more expensive drug. With drug prices rising and many people out of work, pharmaceutical companies are …